Study of Muscle Wasting and Altered Metabolism in Patients With Myotonic Dystrophy
NCT00004769 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 130
Last updated 2013-01-28
Summary
OBJECTIVES: I. Examine the interrelationships between muscle wasting (phenotype), the degree of myotonic dystrophy (DM) gene expression (genotype) in patients with DM.
II. Characterize the insulin resistance in these patients. III. Assess the glucose uptake in the leg and forearm tissues of these patients.
IV. Determine the stability of the DM gene lesion in muscles over a 5-10 year period.
Conditions
- Myotonic Muscular Dystrophy
Sponsors & Collaborators
-
University of Rochester
lead OTHER
Principal Investigators
-
Richard T. Moxley, III · University of Rochester
Eligibility
- Min Age
- 21 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 1993-12-31
- Primary Completion
- 2000-03-31
- Completion
- 2000-03-31
More Related Trials
-
Contractile Cross Sectional Areas and Muscle Strength in Patients With Congenital Myopathies
NCT03018184 ·Status: COMPLETED
-
Assessing Clinical Endpoints and Biomarkers in Myotonic Dystrophy Type-1 and Type 2 (ASCEND-DM)
NCT03867435 ·Status: TERMINATED
-
Biomarker Development for Muscular Dystrophies
NCT05019625 ·Status: RECRUITING
-
Molecular Analysis of Patients With Neuromuscular Disease
NCT00390104 ·Status: RECRUITING
-
A Registered Cohort Study on Duchenne Muscular Dystrophy
NCT04012671 ·Status: RECRUITING
-
Safety and Dose Finding Study of NS-065/NCNP-01 in Boys With Duchenne Muscular Dystrophy (DMD)
NCT02740972 ·Status: COMPLETED ·Phase: PHASE2
-
Extracellular RNA Biomarkers of Duchenne Muscular Dystrophy
NCT05016908 ·Status: RECRUITING
-
The Baby Duchenne Study: Characterizing Developmental and Clinical Outcomes in the First Three Years in Children With Duchenne Muscular Dystrophy
NCT07092540 ·Status: RECRUITING
-
An MRI Study on Muscular Diseases -Pompe Disease and Dystrophia Myotonica-
NCT02708784 ·Status: UNKNOWN
-
Strength Training in Duchenne Muscular Dystrophy
NCT02421523 ·Status: COMPLETED ·Phase: NA
-
Characteristics of Nondystrophic Myotonias
NCT00244413 ·Status: COMPLETED
-
Non-invasive Imaging of Muscle Structure in Duchenne Muscular Dystrophy Using Multispectral Optoacoustic Tomography
NCT03490214 ·Status: COMPLETED ·Phase: NA
-
Biomechanical Analysis of Gait in Individuals With Duchenne Muscular Dystrophy
NCT00312247 ·Status: COMPLETED
-
Evaluation of Muscle miRNA as Biomarkers in Dystrophinopathies
NCT02109692 ·Status: UNKNOWN ·Phase: NA
-
Exploratory Study of NS-065/NCNP-01 in DMD
NCT02081625 ·Status: COMPLETED ·Phase: PHASE1
-
L-citrulline and Metformin in Duchenne's Muscular Dystrophy
NCT01995032 ·Status: COMPLETED ·Phase: PHASE3
-
Improved Muscle Function in Duchenne Muscular Dystrophy Through L-Arginine and Metformin
NCT02516085 ·Status: COMPLETED ·Phase: PHASE1
-
A Multicenter Phenotype-Genotype Analysis of DM1 Patients in China
NCT06101940 ·Status: ENROLLING_BY_INVITATION
-
Gentamicin Treatment of Muscular Dystrophy
NCT00005574 ·Status: COMPLETED ·Phase: PHASE1
-
Duchenne Muscular Dystrophy < 18y in Norway: Genotype/Phenotype, Growth, Puberty, Bone Health and Quality of Life.
NCT01963897 ·Status: COMPLETED
-
A Multicenter Randomized Placebo-Controlled Double-Blind Study to Assess Efficacy and Safety of Glutamine and Creatine Monohydrate in Duchenne Muscular Dystrophy (DMD)
NCT00018109 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical and Functional Assessment of Patients With Inherited Non-Duchenne Myopathies in Sohag University Hospital
NCT06574919 ·Status: RECRUITING
-
Aerobic Training in Patients With Congenital Myopathies
NCT02020187 ·Status: COMPLETED ·Phase: NA
-
Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-101 in Participants With Myotonic Dystrophy Type 1
NCT05481879 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Extracellular RNA Biomarkers of Myotonic Dystrophy
NCT05020002 ·Status: RECRUITING